IP Library Granted Patent US 7,509,153
Granted Patent B2
US 7,509,153 · App. 10/384,049 · Granted Mar 24, 2009

Method and apparatus for control of skin perfusion for indirect glucose measurement

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,509,153
App. No.
10/384,049
Granted
Mar 24, 2009
Kind
B2
Abstract

A method and apparatus for noninvasive glucose measurement measures glucose indirectly from the natural response of tissue to variations in analyte concentration. The indirect measurement method utilizes factors affected by or correlated with the concentration of glucose, such as refractive index, electrolyte distribution or tissue scattering. Measurement reliability is greatly improved by stabilizing optical properties of the tissue at the measurement site, thus blood perfusion rates at the sample site are regulated. Perfusion is monitored and stabilized by spectroscopically measuring a control parameter, such as skin temperature, that directly affects perfusion. The control parameter is maintained in a range about a set point, thus stabilizing perfusion. Skin temperature is controlled using a variety of means, including the use of active heating and cooling elements, passive devices, such as thermal wraps, and through the use of a heated coupling medium having favorable heat transfer properties.

Claims (36)

1. A noninvasive method of measuring a tissue analyte, comprising steps of:

controlling skin temperature proximate sampling tissue by applying a coupling medium, said coupling medium comprising a liquid having been pre-heated apart from the tissue;

collecting an analytical signal from the tissue, said collected signal comprising a tissue measurement;

extracting at least one feature from the analytical signal indicative of the effect of the target analyte on the probed tissue;

performing one of: correcting a direct analyte measurement based on said at least one feature, or calculating concentration of said analyte indirectly by application of a calibration model to said at least one feature.

2. The method of claim 1 ,

further comprising a step of pre-heating the coupling medium apart from the tissue prior to applying the coupling medium.

3. The method of claim 1 , where the step of collecting an analytical signal from the tissue comprises:

directing near-infrared energy upon the tissue via the coupling medium and measuring one or more properties of infrared energy exiting the tissue.

4. The method of claim 1 , the coupling medium comprising one of:

a perfluorocarbon, or a fluorocarbon.

5. The method of claim 1 , wherein said coupling medium comprises any of:

silicone oil;

mineral oil; or

glycerol.

6. The method of claim 1 , wherein said coupling medium comprises a perfluorocarbon liquid.

7. The method of claim 6 , wherein said perfluorocarbon liquid has a fluorocarbon chain length of at least twelve carbons.

8. The method of claim 7 , wherein said perfluorocarbon liquid has a fluorocarbon chain length of at least fifteen carbons.

9. The method of claim 1 , wherein skin temperature is controlled to between approximately 30 and 40 degrees centigrade.

10. The method of claim 9 , wherein skin temperature is controlled to between approximately 30 and 35 degrees centigrade.

11. The method of claim 1 , wherein skin temperature is maintained to within approximately 1 degree centigrade of a set point.

12. The method of claim 11 , wherein outermost 100 μm of said skin is controlled to within approximately 1 degree centigrade of a set point.

13. The method of claim 1 , wherein said analyte comprises glucose.

14. The method of claim 1 , wherein said feature represents redistribution of fluids between at least two of:

an extra-cellular compartment;

an intra-cellular compartment;

an extra-vascular compartment; and

an intra-vascular compartment.

15. The method of claim 1 , wherein said analytical signal comprises an indirect representation of said concentration of said analyte.

16. The method of claim 15 , wherein said indirect representation comprises a scattering signal.

17. A noninvasive method of measuring a tissue analyte, comprising acts of:

stabilizing optical properties of said tissue at a measurement site;

collecting an analytical signal from the tissue, said collected signal comprising a tissue measurement;

extracting at least one feature from the analytical signal indicative of the effect of the target analyte on the probed tissue; and

calculating concentration of said analyte indirectly by application of a calibration model to said feature;

where the act of stabilizing optical properties comprises controlling skin temperature at the measurement site by performing acts comprising: an operator applying a thermal wrap.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2012
From: SENSYS MEDICAL, LIMITED
To: GLT ACQUISITION CORP.
Reel/Frame 028912/0036 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2012
From: SENSYS MEDICAL, INC.
To: SENSYS MEDICAL, LTD
Reel/Frame 028714/0623 →
LIEN RELEASE Recorded Apr 14, 2009
From: GLENN PATENT GROUP
To: SENSYS MEDICAL, INC.
Reel/Frame 022542/0360 →
LIEN Recorded Jan 20, 2009
From: SENSYS MEDICAL, INC.
To: GLENN PATENT GROUP
Reel/Frame 022117/0887 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2003
From: BLANK, THOMAS B.; RUCHTI, TIMOTHY L.; MATTU, MUTUA; MAKAREWICZ, MARCY; MONFRE, STEPHEN L.; LORENZ, ALEXANDER D.
To: SENSYS MEDICAL, INC.
Reel/Frame 014249/0966 →